ABSTRACT
A remetalation (a capping group exchange) reaction of the boronantimony-capped iron(II) clathrochelates with zirconium and hafnium(IV) phthalocyanines in CH2Cl2/CH3OH medium afforded the hybrid phthalocyaninoclathrochelates in a practically quantitative yield. The complexes obtained have been characterized both on the basis of elemental analysis, PD mass spectrometry, IR, UV-vis, 57Fe Mössbauer, and NMR spectroscopies, and crystallographically. An encapsulated iron(II) ion in an intermediate between a trigonal-prismatic and a trigonal-antiprismatic environment of six nitrogen atoms of the macrobicyclic ligand was found to be in a low-spin state. The cyclic voltammograms show irreversible oxidation and reduction waves assignable to Fe+/Fe2+ couples of macrobicyclic fragments and to phthalocyanine macrocycles.
ABSTRACT
The new axially substituted phthalocyanine (pc) complex of zirconium(IV) with citric acid is reported. It has been shown that the replacement of two Cl-atoms with two citric acid fragments takes place as the result of the reaction between [ZrCl2(pc)] and citric acid. The complex [Zr(citrate)2(pc)] was formed. The spectroscopic properties of the synthesized compound in DMSO, RPMI 1640 medium with and without fetal calf serum (FCS), H2O, and buffer (Tris) solutions have been described. Antitumor activity of this compound has been studied. The cytostatic activity was observed in the concentration range of 6.1-9.0x10(9) molecules [Zr(citrate)2(pc)]/cell and occurred in 4-6 h after treatment with [Zr(citrate)2(pc)] solution.
